希少バイオマーカー検体の収集と安定化の世界市場レポート 2025年

希少バイオマーカー検体の収集と安定化市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.3％で524億6,000万米ドルに成長します。予測期間の成長は、リキッドバイオプシー応用の拡大、消費者の認識と需要、非侵襲的技術の採用増加、希少疾患におけるバイオマーカー探索に起因すると考えられます。予測期間の主な動向には、保存技術の進歩、ゲノムおよびプロテオミクス研究の成長、ポイントオブケア検査の出現、規制の進歩と標準化、データ分析の強化、AIの統合などがあります。

がんの有病率の増加は、希少バイオマーカー検体収集・安定化市場の成長を促進すると予想されます。異常細胞の無秩序な増殖と拡散を特徴とするがんは、環境汚染物質や、遺伝的素因を悪化させる喫煙や食生活の乱れなどの生活習慣要因によって有病率が上昇しています。希少バイオマーカー検体の収集と安定化法をがん有病率調査に利用することで、特定のがん種のより正確な検出とモニタリングが容易になり、診断と治療アプローチが強化されます。例えば、2023年10月、欧州を拠点とする管理機関である欧州委員会の報告書によると、2022年の新規がん症例は274万人に上り、2020年からの2.3％増を反映しています。その結果、がんの有病率の増加が希少バイオマーカー検体収集・安定化市場の成長を牽引しています。

希少バイオマーカー検体採取・安定化市場の主要企業は、マルチオミクス・リキッドバイオプシー用の血漿や細胞サンプルの調製を自動化するための前処理プラットフォームなど、革新的ソリューションの開発に注力しています。分析前プラットフォームは、採血時に一貫した自動新鮮サンプル調製を提供し、特別なチューブや熟練した専門家を必要とせず、全血の完全なウォークアウェイ処理を可能にするため、サンプルの完全性が保たれます。例えば、2022年5月、イタリアのバイオテクノロジー企業であるTethis S.p.A.は、See.dを発売しました。See.dは、精密なサンプルハンドリング、血漿と細胞分画の効率的な分離、SmartBioSurfaceスライドへの白血球の固定といった独自の機能を提供する、初の完全自動化された標準化された分析前プラットフォームです。このプラットフォームには、サンプルの安定性を客観的に評価するための品質管理スコアリングシステムが含まれており、プロテオミクスとメタボロミクスのデータセットを系統的にスコアリングして、血漿と血清サンプルの安定性を判定することができます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界希少バイオマーカー検体の収集と安定化PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の希少バイオマーカー検体の収集と安定化市場：成長率分析
• 世界の希少バイオマーカー検体の収集と安定化市場の実績：規模と成長, 2019-2024
• 世界の希少バイオマーカー検体の収集と安定化市場の予測：規模と成長, 2024-2029, 2034F
• 世界希少バイオマーカー検体の収集と安定化総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の希少バイオマーカー検体の収集と安定化市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 循環細胞遊離デオキシリボ核酸（CCFDNA）
• 循環腫瘍細胞（CTC）
• エクソソームまたは細胞外小胞
• 世界の希少バイオマーカー検体の収集と安定化市場標本別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血清または血漿
• その他の標本
• 世界の希少バイオマーカー検体の収集と安定化市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非侵襲的出生前検査（NIPT）
• 腫瘍学
• トランスクリプトミクス
• 薬理ゲノミクス
• 移植拒絶反応
• 人口スクリーニング
• 心血管疾患
• その他の用途
• 世界の希少バイオマーカー検体の収集と安定化市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 周産期クリニック
• 公衆衛生研究所
• 民間または商業ラボ
• 医師ラボ
• 調査機関
• その他のエンドユーザー
• 世界の希少バイオマーカー検体の収集と安定化市場循環遊離細胞デオキシリボ核酸（CCFDNA）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血漿CCFDNA
• 血清CCFDNA
• 世界の希少バイオマーカー検体の収集と安定化市場循環腫瘍細胞（CTC）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液中のCTC
• 骨髄中のCTC
• 世界の希少バイオマーカー検体の収集と安定化市場エクソソームまたは細胞外小胞の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血漿からのエクソソーム
• 血清からのエクソソーム

第7章 地域別・国別分析

• 世界の希少バイオマーカー検体の収集と安定化市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の希少バイオマーカー検体の収集と安定化市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 希少バイオマーカー検体の収集と安定化市場：競合情勢
• 希少バイオマーカー検体の収集と安定化市場：企業プロファイル
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Eurofins Scientific SE
• Agilent Technologies Inc.
• PerkinElmer Inc.
• Illumina Inc.
• Charles River Laboratories International Inc.
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• QIAGEN N.V.
• Miltenyi Biotec GmbH
• Natera Inc.
• Promega Corporation
• Myriad Genetics
• Hamilton Company
• OraSure Technologies Inc.
• Fluidigm Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 希少バイオマーカー検体の収集と安定化市場2029：新たな機会を提供する国
• 希少バイオマーカー検体の収集と安定化市場2029：新たな機会を提供するセグメント
• 希少バイオマーカー検体の収集と安定化市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Rare biomarkers specimen collection and stabilization involves the process of gathering and preserving biological samples that contain rare or low-abundance molecules, which indicate specific biological processes, diseases, or conditions. These biomarkers can include specific proteins, nucleic acids, metabolites, or other substances. The goal of collecting and preserving these rare biomarkers is to allow for accurate and reliable measurement and analysis for diagnostic, prognostic, and therapeutic purposes.

The primary types of rare biomarker specimen collection and stabilization include circulating cell-free DNA (ccFDNA), circulating tumor cells (CTCs), exosomes, and extracellular vesicles. Circulating cell-free DNA (ccFDNA) consists of DNA fragments freely circulating in the bloodstream, originating from both healthy and diseased cells. These fragments carry genetic information and can be analyzed for various diagnostic purposes, such as cancer detection or monitoring treatment effectiveness. Various specimens, such as serum or plasma, are used for applications including non-invasive prenatal testing (NIPT), oncology, transcriptomics, pharmacogenomics, transplant rejection, population screening, cardiovascular diseases, and others. These specimens are utilized by a range of end-users, including hospitals, perinatal clinics, public health labs, private or commercial labs, physician labs, research institutes, and others.

The rare biomarkers specimen collection and stabilization market research report is one of a series of new reports from The Business Research Company that provides rare biomarkers specimen collection and stabilization market statistics, including the rare biomarkers specimen collection and stabilization industry global market size, regional shares, competitors with rare biomarkers specimen collection and stabilization market share, detailed rare biomarkers specimen collection and stabilization market segments, market trends, and opportunities, and any further data you may need to thrive in the rare biomarkers specimen collection and stabilization industry. These rare biomarkers specimen collection and stabilization market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The rare biomarkers specimen collection and stabilization market size has grown rapidly in recent years. It will grow from $32.01 billion in 2024 to $35.4 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to the human genome project, increase in cancer research, pharmaceutical R&D investment, growth of genomics and proteomics, and improved data management and bioinformatics.

The rare biomarkers specimen collection and stabilization market size is expected to see rapid growth in the next few years. It will grow to $52.46 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to the expansion of liquid biopsy applications, consumer awareness and demand, increasing adoption of non-invasive techniques, and biomarker discovery in rare diseases. Major trends in the forecast period include advancements in preservation technology, growth in genomic and proteomic research, the emergence of point-of-care testing, and regulatory advancements and standardization, enhanced data analytics, and AI integration.

The increasing prevalence of cancer is expected to propel the growth of the rare biomarker specimen collection and stabilization market. Cancer, characterized by the uncontrolled proliferation and spread of abnormal cells, is rising in prevalence due to environmental pollutants and lifestyle factors, such as smoking and poor diet choices, which exacerbate genetic predispositions. The utilization of rare biomarker specimen collection and stabilization methods in cancer prevalence studies facilitates more accurate detection and monitoring of specific cancer types, thereby enhancing diagnostic and therapeutic approaches. For example, in October 2023, a report by the European Commission, a Europe-based governing body, indicated that new cancer cases rose to 2.74 million in 2022, reflecting a 2.3% increase from 2020. Consequently, the increasing prevalence of cancer is driving the growth of the rare biomarker specimen collection and stabilization market.

Major companies in the rare biomarker specimen collection and stabilization market are focusing on developing innovative solutions, such as pre-analytical platforms to automate the preparation of plasma and cell samples for multiomic liquid biopsy. Pre-analytical platforms provide consistent, automated fresh sample preparation at the time of blood collection, allowing for complete walk-away processing of whole blood without the need for special tubes or skilled professionals, thus preserving sample integrity. For instance, in May 2022, Tethis S.p.A., an Italy-based biotechnology company, launched See.d, the first fully automated, standardized pre-analytical platform offering unique features such as precise sample handling, efficient separation of plasma for cellular fractions, and fixation of white blood cells on SmartBioSurface slides. The platform includes a quality control scoring system for objectively evaluating sample stability, enabling the systematic scoring of proteomics and metabolomics data sets to determine the stability of plasma and serum samples.

In October 2022, DiaSorin, an Italy-based biotechnology company, acquired Luminex Corporation for an undisclosed amount. With this acquisition, DiaSorin aims to leverage multiplexing technology and Luminex's portfolio to strengthen its existing offerings. This acquisition aims to enhance DiaSorin's diagnostic testing capabilities, expand its market presence, and drive innovation in the molecular and immunodiagnostics sectors. Luminex Corporation is a US-based provider of proprietary biological testing instruments involving rare biomarker specimen collection and stabilization.

Major companies operating in the rare biomarkers specimen collection and stabilization market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Miltenyi Biotec GmbH, Natera Inc., Promega Corporation, Myriad Genetics, Hamilton Company, OraSure Technologies Inc., Fluidigm Corporation, Streck Inc., SeraCare, Enzo Biochem Inc., Epigenomics AG, Veridex LLC

North America was the largest region in the rare biomarkers specimen collection and stabilization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare biomarkers specimen collection and stabilization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the rare biomarkers specimen collection and stabilization market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The rare biomarkers specimen collection and stabilization market consists of revenues earned by entities by providing services such as sample collection, stabilization and preservation, customized collection protocols, bio banking and storage and data management and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The rare biomarkers specimen collection and stabilization market also includes sales of biomarker collection kits, laboratory equipment, training and educational materials, quality control materials, and sample storage containers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Rare Biomarkers Specimen Collection And Stabilization Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rare biomarkers specimen collection and stabilization market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rare biomarkers specimen collection and stabilization ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The rare biomarkers specimen collection and stabilization market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Circulating Cell Free Deoxyribonucleic Acid (CCFDNA); Circulating Tumor Cells (CTCs); Exosomes or Extracellular Vesicles
• 2) By Specimen: Serum Or Plasma; Other Specimens
• 3) By Application: Non-Invasive Prenatal Testing (NIPT); Oncology; Transcriptomics; Pharmacogenomics; Transplant Rejection; Population Screening; Cardiovascular Diseases; Other Applications
• 4) By End-User: Hospitals; Perinatal Clinics; Public Health Labs; Private Or Commercial Labs; Physician Labs; Research Institutes; Other End-Users
• Subsegments:
• 1) By Circulating Cell Free Deoxyribonucleic Acid (CCFDNA): Plasma CCFDNA; Serum CCFDNA
• 2) By Circulating Tumor Cells (CTCs): CTCs In Blood; CTCs In Bone Marrow
• 3) By Exosomes Or Extracellular Vesicles: Exosomes From Plasma; Exosomes From Serum
• Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Merck KGaA; Becton Dickinson and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Rare Biomarkers Specimen Collection And Stabilization Market Characteristics

3. Rare Biomarkers Specimen Collection And Stabilization Market Trends And Strategies

4. Rare Biomarkers Specimen Collection And Stabilization Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Rare Biomarkers Specimen Collection And Stabilization Growth Analysis And Strategic Analysis Framework

• 5.1. Global Rare Biomarkers Specimen Collection And Stabilization PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Rare Biomarkers Specimen Collection And Stabilization Market Growth Rate Analysis
• 5.4. Global Rare Biomarkers Specimen Collection And Stabilization Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Rare Biomarkers Specimen Collection And Stabilization Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Rare Biomarkers Specimen Collection And Stabilization Total Addressable Market (TAM)

6. Rare Biomarkers Specimen Collection And Stabilization Market Segmentation

• 6.1. Global Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Circulating Cell Free Deoxyribonucleic Acid (CCFDNA)
• Circulating Tumor Cells (CTCs)
• Exosomes Or Extracellular Vesicles
• 6.2. Global Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Serum Or Plasma
• Other Specimens
• 6.3. Global Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Invasive Prenatal Testing (NIPT)
• Oncology
• Transcriptomics
• Pharmacogenomics
• Transplant Rejection
• Population Screening
• Cardiovascular Diseases
• Other Applications
• 6.4. Global Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Perinatal Clinics
• Public Health Labs
• Private Or Commercial Labs
• Physician Labs
• Research Institutes
• Other End-Users
• 6.5. Global Rare Biomarkers Specimen Collection And Stabilization Market, Sub-Segmentation Of Circulating Cell Free Deoxyribonucleic Acid (CCFDNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plasma CCFDNA
• Serum CCFDNA
• 6.6. Global Rare Biomarkers Specimen Collection And Stabilization Market, Sub-Segmentation Of Circulating Tumor Cells (CTCs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CTCs In Blood
• CTCs In Bone Marrow
• 6.7. Global Rare Biomarkers Specimen Collection And Stabilization Market, Sub-Segmentation Of Exosomes or Extracellular Vesicles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Exosomes From Plasma
• Exosomes From Serum

7. Rare Biomarkers Specimen Collection And Stabilization Market Regional And Country Analysis

• 7.1. Global Rare Biomarkers Specimen Collection And Stabilization Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Rare Biomarkers Specimen Collection And Stabilization Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market

• 8.1. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Rare Biomarkers Specimen Collection And Stabilization Market

• 9.1. China Rare Biomarkers Specimen Collection And Stabilization Market Overview
• 9.2. China Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Rare Biomarkers Specimen Collection And Stabilization Market

• 10.1. India Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Rare Biomarkers Specimen Collection And Stabilization Market

• 11.1. Japan Rare Biomarkers Specimen Collection And Stabilization Market Overview
• 11.2. Japan Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Rare Biomarkers Specimen Collection And Stabilization Market

• 12.1. Australia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Rare Biomarkers Specimen Collection And Stabilization Market

• 13.1. Indonesia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Rare Biomarkers Specimen Collection And Stabilization Market

• 14.1. South Korea Rare Biomarkers Specimen Collection And Stabilization Market Overview
• 14.2. South Korea Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Rare Biomarkers Specimen Collection And Stabilization Market

• 15.1. Western Europe Rare Biomarkers Specimen Collection And Stabilization Market Overview
• 15.2. Western Europe Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Rare Biomarkers Specimen Collection And Stabilization Market

• 16.1. UK Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Rare Biomarkers Specimen Collection And Stabilization Market

• 17.1. Germany Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Rare Biomarkers Specimen Collection And Stabilization Market

• 18.1. France Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Rare Biomarkers Specimen Collection And Stabilization Market

• 19.1. Italy Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Rare Biomarkers Specimen Collection And Stabilization Market

• 20.1. Spain Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Rare Biomarkers Specimen Collection And Stabilization Market

• 21.1. Eastern Europe Rare Biomarkers Specimen Collection And Stabilization Market Overview
• 21.2. Eastern Europe Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Rare Biomarkers Specimen Collection And Stabilization Market

• 22.1. Russia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Rare Biomarkers Specimen Collection And Stabilization Market

• 23.1. North America Rare Biomarkers Specimen Collection And Stabilization Market Overview
• 23.2. North America Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Rare Biomarkers Specimen Collection And Stabilization Market

• 24.1. USA Rare Biomarkers Specimen Collection And Stabilization Market Overview
• 24.2. USA Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Rare Biomarkers Specimen Collection And Stabilization Market

• 25.1. Canada Rare Biomarkers Specimen Collection And Stabilization Market Overview
• 25.2. Canada Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Rare Biomarkers Specimen Collection And Stabilization Market

• 26.1. South America Rare Biomarkers Specimen Collection And Stabilization Market Overview
• 26.2. South America Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Rare Biomarkers Specimen Collection And Stabilization Market

• 27.1. Brazil Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Rare Biomarkers Specimen Collection And Stabilization Market

• 28.1. Middle East Rare Biomarkers Specimen Collection And Stabilization Market Overview
• 28.2. Middle East Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Rare Biomarkers Specimen Collection And Stabilization Market

• 29.1. Africa Rare Biomarkers Specimen Collection And Stabilization Market Overview
• 29.2. Africa Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Rare Biomarkers Specimen Collection And Stabilization Market Competitive Landscape And Company Profiles

• 30.1. Rare Biomarkers Specimen Collection And Stabilization Market Competitive Landscape
• 30.2. Rare Biomarkers Specimen Collection And Stabilization Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Rare Biomarkers Specimen Collection And Stabilization Market Other Major And Innovative Companies

• 31.1. Eurofins Scientific SE
• 31.2. Agilent Technologies Inc.
• 31.3. PerkinElmer Inc.
• 31.4. Illumina Inc.
• 31.5. Charles River Laboratories International Inc.
• 31.6. Bio-Rad Laboratories Inc.
• 31.7. Bruker Corporation
• 31.8. QIAGEN N.V.
• 31.9. Miltenyi Biotec GmbH
• 31.10. Natera Inc.
• 31.11. Promega Corporation
• 31.12. Myriad Genetics
• 31.13. Hamilton Company
• 31.14. OraSure Technologies Inc.
• 31.15. Fluidigm Corporation

32. Global Rare Biomarkers Specimen Collection And Stabilization Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Rare Biomarkers Specimen Collection And Stabilization Market

34. Recent Developments In The Rare Biomarkers Specimen Collection And Stabilization Market

35. Rare Biomarkers Specimen Collection And Stabilization Market High Potential Countries, Segments and Strategies

• 35.1 Rare Biomarkers Specimen Collection And Stabilization Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Rare Biomarkers Specimen Collection And Stabilization Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Rare Biomarkers Specimen Collection And Stabilization Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer